AGP Executive Report
Last update: 10 hours agoDutch Biotech: Amsterdam-based VectorY Therapeutics raised €74.5 million to advance treatments for neurodegenerative diseases, including an ALS therapy in clinical trials. Skin Cancer: A study spanning more than 30 years found rising rates of squamous cell carcinoma in the Netherlands and other countries, with increases generally faster among women. Researchers point to cumulative UV exposure and call for more attention to prevention. Addiction Care: Amsterdam is putting €6 million toward extra shelter, treatment and support for people facing addiction and homelessness, including 37 new overnight places from December. Brain Health: Radboudumc researchers are combining gut microbiome data and brain scans to investigate how the gut-brain connection may relate to mental health. Medical Research: The Dutch Senate narrowly approved a law allowing embryos to be created for research.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.